Call us: +46-31-760 80 05 Mail us: info@micropos.se
Micropos Medical Enables hypofractionated radiotherapy for prostate cancer

News

13 April 2021

Micropos Medical planerar en företrädesemission (only in Swedish)

Micropos Medical AB har under 2020 introducerat RayPilot HypoCath, ett system för realtidspositionering vid strålningsbehandling av prostatacancer. Produkten har fått ett positivt mottagande och nya…

Read more
24 March 2021

New distributor in the MENA region

Micropos Medical AB and Enox Pharma AB are proud to announce their intention to collaborate in the MENA region with an initial focus on Egypt, Iraq, Saudi Arabia and the…

Read more
22 March 2021

First RayPilot® HypoCath® patient in Salzburg, Austria

Univ. Prof. Dr. Felix Sedlmayer, member of DEGRO working group prostate cancer, and his team at the Paracelus Medical University Hospital (named SALK) in Salzburg,…

Read more
19 March 2021

Health Europa has published the article "Improved accuracy in prostate cancer treatment"

Click on the image for the full article:

Read more
15 March 2021

First RayPilot® HypoCath® patient in Ulm, Germany

Prof. Dr. Thomas Wiegel, member of DEGRO working group prostate cancer, and his team at the university hospital in Ulm, Germany has performed their first…

Read more
10 March 2021

First RayPilot® system with HypoCath® installed in Belarus

The latest prostate tracking solution RayPilot system with HypoCath has been installed at Minsk City Clinical Oncologic Dispensary in Minsk. This is the first installation…

Read more
18 February 2021

Micropos Medical AB (publ) has published the year-end report for 2020

To read or download the year-end report for 2020 (only in Swedish), please click here  

Read more
22 January 2021

Micropos Medical AB. New product is CE marked

Micropos Medical AB announces on the Thursday 21:th of January,  that the company has received its new product, RayPilot ViewCath CE approved. RayPilot ViewCath receives…

Read more
29 October 2020

New clinical data from Edinburgh Cancer Center and Liverpool University, Directory of RT.

At Micropos Medical, we are very pleased with the work presented by the Edinburgh Cancer Center (ECC) UK and the Liverpool University Directorate of Radiotherapy…

Read more
30 September 2020

BIOLOGY MEETS TECHNOLOGY: SBRT FOR LOCALIZED PROSTATE CANCER:

”- RayPilot HypoCath enables us to keep track of prostate motion during SBRT treatments where the precise dose to the target and strict tolerance to…

Read more